Tag: FOR

As Consumer Demand Surges for Lab-Tested Botanical Products, Super Speciosa Responds With a Timely Tincture Update and GMP-Backed Transparency

Buffalo, NY, July 25, 2025 (GLOBE NEWSWIRE) -- POP Biotechnologies (POP BIO), a biotechnology company specializing in nanoparticle-based vaccines, and the Coalition for Epidemic Preparedness Innovations (CEPI) have announced a new collaboration to accelerate the development of vaccines against future pandemic threats, including a potential ‘Disease X’. Backed by up to $1.5 million in funding from CEPI, the partnership will advance POP BIO’s SNAP™ (Spontaneous Nanoliposome Antigen Particleization) platform—a plug-and-play technology designed to enable rapid-response vaccine development through streamlined protein purification and nanoparticle delivery.

Vesper Holdings and Fortress Investment Group Recapitalize Hawks Pointe, a 463-bed student housing community at the University of Kansas

Today, KPN announces the completion of its € 250m share buyback, which commenced on 25 February 2025 and was completed on 25 July 2025. In total, KPN has repurchased 62,465,117 ordinary shares at an average price of € 4.00 per share.

A Natural Supplement Trend in 2025, Menovelle Helps Women Support Hormonal Balance and Metabolic Energy Without Hormone Therapy or Stimulants

WASHINGTON, July 25, 2025 (GLOBE NEWSWIRE) -- EB5 Capital is pleased to announce the first individual I-526E petition approval for an investor in its Charlotte Eagle Lake (JF42) project. An I-526E approval is a significant step in the EB-5 immigration process as it qualifies the investor and their eligible family members for conditional permanent residency in the United States. The approved petition was filed in January 2025 and was pending for approximately six months.